Decision Tool
View More
Enter asthma patient characteristics in this online CCO tool and compare your treatment plan with those of 5 experts.
Expert commentaries detailing why determining endotype is crucial to managing severe asthma and how targeted biologic therapies have advanced treatment for type 2 asthma.
Why determining endotype is crucial to managing severe asthma.
Here’s why targeted biologic therapies are a great advance for treating type 2 asthma.
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.